Immune response study of histotripsy in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests how your body's immune system reacts to a treatment called histotripsy for colorectal cancer that has spread to the liver. Histotripsy uses sound waves to break apart tumors, and the study aims to see if this can help your immune system fight the cancer better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have colorectal cancer that has spread to the liver and is confirmed by a biopsy. The cancer type must be microsatellite stable (MSS).
- You must be scheduled to receive standard histotripsy treatment for your liver tumors.
- Your liver tumors must be visible on a CT or MRI scan done within the last 60 days.
- Your blood counts, kidney, and liver function should be within certain safe limits, as determined by your doctor.
- You must be able to understand and sign a consent form and have an expected survival of at least 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding histotripsy—a non-invasive ultrasound treatment that destroys liver tumors—to standard chemotherapy improves outcomes for people with advanced colorectal cancer that has spread to the liver. It may be an option if your cancer is mainly in the liver and you are starting or have recently had chemotherapy.
This trial tests a new non-invasive ultrasound technique called histotripsy to relieve pain and discomfort from inoperable tumors in the abdomen, such as liver or pancreatic cancer. It may be an option if you have a tumor that cannot be surgically removed and you are looking for symptom relief.
This study tests a new, noninvasive treatment called histotripsy that uses sound waves to destroy small liver tumors. It is for people whose liver cancer hasn't spread much and who haven't had success with or can't have surgery or other standard treatments.
This trial tests a combination of precise radiation to liver or lung tumors plus immunotherapy for people with advanced colorectal cancer that cannot be surgically removed. It aims to see if this approach can help control the cancer.
This trial compares two ways to treat colorectal cancer that has spread to the liver and cannot be removed by surgery. It tests if combining a targeted chemo bead procedure (DEB-TACE) with liver chemo infusion (HAIC) works better than HAIC alone.
This study tests a new, non-invasive procedure called histotripsy that uses sound waves to break apart liver tumors located near important blood vessels. It may be an option for people whose tumors are too risky to remove with surgery.
Hear when a new Colorectal (Colon or Rectal) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.